Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GULDSMED BØRGE HANSEN & SØN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   9.9% 10.9% 9.2% 4.5% 11.5% 10.4% 12.0% 11.7%   Credit score (0-100)   26 24 27 45 20 22 20 20   Credit rating   BB BB BB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   979 865 827 1,276 1,141 945 0.0 0.0   EBITDA   148 -13.2 134 426 87.1 -55.3 0.0 0.0   EBIT   105 -55.4 128 420 86.1 -62.3 0.0 0.0   Pre-tax profit (PTP)   18.2 -107.3 73.4 388.8 32.2 -201.9 0.0 0.0   Net earnings   18.2 -107.3 73.4 454.7 18.0 -158.8 0.0 0.0   Pre-tax profit without non-rec. items   18.2 -107 73.4 389 32.2 -202 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   55.8 13.7 7.3 1.1 0.0 39.7 0.0 0.0   Shareholders equity total   865 758 831 1,286 1,075 916 586 586   Interest-bearing liabilities   1,848 1,683 1,569 1,442 2,041 1,968 0.0 0.0   Balance sheet total (assets)   3,296 3,178 3,370 3,976 4,019 3,785 586 586   Net Debt   1,845 1,678 1,539 1,402 2,026 1,952 -586 -586     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   979 865 827 1,276 1,141 945 0.0 0.0   Gross profit growth   -9.8% -11.6% -4.4% 54.3% -10.6% -17.2% -100.0% 0.0%   Employees   3 3 3 2 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% -33.3% 50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,296 3,178 3,370 3,976 4,019 3,785 586 586   Balance sheet change%   -7.5% -3.6% 6.0% 18.0% 1.1% -5.8% -84.5% 0.0%   Added value   147.6 -13.2 133.9 426.5 92.4 -55.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -86 -84 -13 -13 -2 33 -40 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 2.0 3.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.7% -6.4% 15.4% 32.9% 7.5% -6.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.1% -1.7% 3.9% 11.8% 2.4% -1.6% 0.0% 0.0%   ROI %   3.8% -2.1% 5.2% 16.4% 3.2% -2.0% 0.0% 0.0%   ROE %   2.1% -13.2% 9.2% 43.0% 1.5% -15.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   26.2% 23.8% 24.7% 32.3% 26.7% 24.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,249.5% -12,702.6% 1,149.4% 328.8% 2,326.5% -3,531.5% 0.0% 0.0%   Gearing %   213.6% 222.1% 188.7% 112.1% 189.8% 214.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.6% 2.9% 3.3% 2.9% 3.7% 7.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0   Current Ratio   2.1 2.1 2.2 2.3 2.0 2.0 0.0 0.0   Cash and cash equivalent   2.9 5.5 29.6 39.6 14.2 16.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,688.5 1,641.8 1,785.7 2,245.4 2,035.6 1,837.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   49 -4 45 213 31 -18 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   49 -4 45 213 29 -18 0 0   EBIT / employee   35 -18 43 210 29 -21 0 0   Net earnings / employee   6 -36 24 227 6 -53 0 0